Renal Cancers Completed Phase 2 Trials for Carfilzomib (DB08889)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01775930Carfilzomib in Refractory Renal Cell Carcinoma (RCC)Treatment